ND10(Theialife Inc)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameND10(Theialife Inc)
Drug Alias NameND10(oral)ND10(Eye Drop)ND10(ER,Oral)7-Methylxanthine a caffeine derivativeND-10 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdenosine A2a receptor modulators
TargetsAdenosine A2a receptor
Therapy Area/IndicationsMyopiaCataractDry Eye Syndromes
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesIndia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesTheialife Inc
China Registration ClassN/A

Develop Information

Active CompaniesTheialife Inc
Inactive CompaniesN/A
Active IndicationsMyopiaCataractDry Eye Syndromes
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A